FNDC5 and metabolic dysfunction-associated steatotic liver disease: Most of studies showed that serum irisin levels were decreased in patients with type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), cardiovascular disease and metabolic bone disease,36, 37 as well as in infants born with neonatal respiratory distress syndrome (NRDS).38